AtriCure
ATRC
145 hedge funds and large institutions have $1.03B invested in AtriCure in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 70 increasing their positions, 38 reducing their positions, and 29 closing their positions.
11,987% more call options, than puts
Call options by funds: $6.41M | Put options by funds: $53K
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
84% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 38
11% more capital invested
Capital invested by funds: $925M → $1.03B (+$105M)
0.16% less ownership
Funds ownership: 89.4% → 89.24% (-0.16%)
9% less funds holding
Funds holding: 160 → 145 (-15)
41% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$10.9M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$10.6M |
| 3 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$10.4M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$9.98M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$7.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$16.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.3M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$8.71M |
| 4 |
HEC
Hudson Executive Capital
New York
|
-$7.6M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$6.51M |
ATRC Hedge Fund Activity: Q2 2019 in Review
145 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q2 2019, worth a combined $1.03B — up 11% from $925M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of ATRC and 17 opened new positions — a net loss of 12 holders — while 38 trimmed existing stakes and 70 added.
The largest buyer was Invesco, adding an estimated $10.9M. The largest seller was Millennium Management, cutting an estimated $16.8M.
- 145 institutional investors held AtriCure (ATRC) as of Q2 2019, down from 160 in Q1 2019.
- Funds reported $1.03B of AtriCure stock for Q2 2019, up 11% quarter-over-quarter.
- 17 funds opened new AtriCure positions in Q2 2019 and 29 closed out, a net change of -12 holders.
- The largest AtriCure buyer in Q2 2019 was Invesco, an estimated $10.9M added.
- The largest AtriCure seller in Q2 2019 was Millennium Management, an estimated $16.8M sold.
Based on aggregated 13F filings for Q2 2019.